BEAM
Price
$21.16
Change
-$0.00 (-0.00%)
Updated
Jul 14, 04:59 PM (EDT)
Capitalization
2.13B
28 days until earnings call
NRIX
Price
$12.69
Change
+$0.25 (+2.01%)
Updated
Jul 14, 04:59 PM (EDT)
Capitalization
970.14M
87 days until earnings call
Interact to see
Advertisement

BEAM vs NRIX

Header iconBEAM vs NRIX Comparison
Open Charts BEAM vs NRIXBanner chart's image
Beam Therapeutics
Price$21.16
Change-$0.00 (-0.00%)
Volume$18.68K
Capitalization2.13B
Nurix Therapeutics
Price$12.69
Change+$0.25 (+2.01%)
Volume$14.71K
Capitalization970.14M
BEAM vs NRIX Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. NRIX commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and NRIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 15, 2025
Stock price -- (BEAM: $21.17 vs. NRIX: $12.44)
Brand notoriety: BEAM and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 104% vs. NRIX: 157%
Market capitalization -- BEAM: $2.13B vs. NRIX: $970.14M
BEAM [@Biotechnology] is valued at $2.13B. NRIX’s [@Biotechnology] market capitalization is $970.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while NRIX’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • NRIX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than NRIX.

Price Growth

BEAM (@Biotechnology) experienced а +10.38% price change this week, while NRIX (@Biotechnology) price change was -2.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.48%. For the same industry, the average monthly price growth was +21.25%, and the average quarterly price growth was +31.32%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

NRIX is expected to report earnings on Oct 09, 2025.

Industries' Descriptions

@Biotechnology (+10.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.13B) has a higher market cap than NRIX($970M). BEAM YTD gains are higher at: -14.637 vs. NRIX (-33.970). NRIX has higher annual earnings (EBITDA): -212.78M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. NRIX (486M). NRIX has less debt than BEAM: NRIX (51.9M) vs BEAM (158M). NRIX has higher revenues than BEAM: NRIX (88.4M) vs BEAM (63.6M).
BEAMNRIXBEAM / NRIX
Capitalization2.13B970M219%
EBITDA-399.03M-212.78M188%
Gain YTD-14.637-33.97043%
P/E RatioN/AN/A-
Revenue63.6M88.4M72%
Total Cash1.22B486M251%
Total Debt158M51.9M304%
TECHNICAL ANALYSIS
Technical Analysis
BEAMNRIX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 22 days ago
85%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WMLIX33.87-0.13
-0.38%
Wilmington Large-Cap Strategy Instl
PINIX14.99-0.10
-0.66%
Principal International Equity Inst
CSSCX20.14-0.21
-1.03%
Columbia Small Cap Value I C
HSMSX13.21-0.14
-1.05%
Hartford Small Cap Value R4
INSAX23.39-0.53
-2.22%
Catalyst Insider Buying A

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.05%
CRSP - BEAM
72%
Closely correlated
-0.67%
NTLA - BEAM
65%
Loosely correlated
+3.60%
RXRX - BEAM
64%
Loosely correlated
N/A
DNLI - BEAM
58%
Loosely correlated
+1.17%
SYRE - BEAM
58%
Loosely correlated
+4.59%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-1.82%
KYMR - NRIX
66%
Closely correlated
-1.61%
IDYA - NRIX
59%
Loosely correlated
-1.40%
DNLI - NRIX
59%
Loosely correlated
-5.41%
RNA - NRIX
56%
Loosely correlated
-0.06%
BEAM - NRIX
56%
Loosely correlated
-3.95%
More